Three leading institutions have joined forces in a bid for funding to become one of five new University Hospital Institutes being set up through France’s stimulus scheme.

Tailoring the treatment to patients is a grand idea. But there are many obstacles. Science|Business organised a roundtable to debate what could be done.

Sanofi-aventis has signed a research partnership with AVIESAN, the French Life Sciences and Healthcare Alliance.